Drug intelligence / Profile preview

methotrexate + 5-fluorouracil + leucovorin

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Oral, Intramuscular, Intrathecal, Topical
01

Overview

This is a combination chemotherapy regimen consisting of methotrexate, 5-fluorouracil (5-FU), and leucovorin (also known as folinic acid). Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, blocking DNA synthesis. 5-Fluorouracil is a pyrimidine analog that inhibits thymidylate synthase and disrupts DNA and RNA synthesis. Leucovorin is a reduced form of folic acid used to "rescue" normal cells from the toxic effects of methotrexate and to enhance the cytotoxicity of 5-fluorouracil by stabilizing its binding to thymidylate synthase. This combination has been used in various solid tumors including colorectal cancer[4][7].

Other names
methotrexate5-FUleucovorinfolinic acid
02

Targets

DHFR (Dihydrofolate reductase)TS (Thymidylate synthase)

Beyond the preview

Go deeper on methotrexate + 5-fluorouracil + leucovorin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methotrexate + 5-fluorouracil + leucovorin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call